Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if his Department will make an assessment of the potential merits of providing testosterone routinely within hormone replacement therapy.
The National Institute for Health and Care Excellence’s (NICE) guideline on the diagnosis and management of menopause published in 2015 recommended that testosterone supplementation should be considered for menopausal women with low sexual desire if hormone replacement therapy alone is not effective. Healthcare professionals should take NICE’s guidelines fully into account in the care and treatment of individual patients. NICE is currently updating its guideline on menopause in light of new evidence and recently consulted on the draft scope of the revised guideline.